A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 714 participants.
Also called NCT05182840
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 714 participants
- Sponsor
- Registry
-
NCT05182840 -
2021-001434-19
-
- Other papers using this trial's data
- Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses
- Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
- Pharmacodynamics of vicadrostat for aldosterone synthase inhibition in patients with CKD
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Finland, Germany, Greece, Hong Kong SAR China, Hungary, India, Italy, Japan, Malaysia, Mexico, Norway, Philippines, Poland, Portugal, South Africa, South Korea, Spain, Sweden, Switzerland, Türkiye
- Registry status
- Completed
Technical summary
Registry record NCT05182840. Randomized; quadruple masking; primary purpose treatment. Start 2022-01-11 (actual); primary completion 2023-06-19 (actual). Results posted on 2024-08-29.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
- Condition
- Kidney Disease, Chronic
- Intervention (Drug)
- BI 690517
- Intervention (Drug)
- Placebo to BI 690517
- Intervention (Drug)
- Empagliflozin
- Intervention (Drug)
- Placebo to empagliflozin
- Lead sponsor
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct05182840- Content hash
aaa8db4c28840f8eb3339fefea890d7a948b2c646b4c859e4b348b5f013fc5d1